Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Cytochrome CYP2B6")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 59

  • Page / 3
Export

Selection :

  • and

Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolismRING, Huijun Z; VALDES, Ana M; NISHITA, Denise M et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 12, pp 1007-1015, issn 1744-6872, 9 p.Article

Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humansKOBAYASHI, Kaoru; MORITA, Jun; CHIBA, Kan et al.Pharmacogenetics (London). 2004, Vol 14, Num 8, pp 549-556, issn 0960-314X, 8 p.Article

Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7ROTGER, Margalida; SAUMOY, Maria; KUNLIN ZHANG et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 10, pp 885-890, issn 1744-6872, 6 p.Article

Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 allelesRESTREPO, Juan Gonzalo; MARTINEZ, Carmen; GARCIA-AGUNDEZ, Augusto et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 12, pp 773-778, issn 1744-6872, 6 p.Article

PharmGKB summary: very important pharmacogene information for CYP2B6THORN, Caroline F; LAMBA, Jatinder K; LAMBA, Vishal et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 8, pp 520-523, issn 1744-6872, 4 p.Article

The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidineJUSHCHYSHYN, Monica I; KENT, Ute M; HOLLENBERG, Paul F et al.Drug metabolism and disposition. 2003, Vol 31, Num 1, pp 46-52, issn 0090-9556, 7 p.Article

Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patientsNAKAJIMA, Miki; KOMAGATA, Sayaka; FUJIKI, Yuto et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 6, pp 431-445, issn 1744-6872, 15 p.Article

Quantitative structure-activity relationship (QSAR) and three-dimensional QSAR analysis of a series of xanthates as inhibitors and inactivators of cytochrome P450 2B1LESIGIARSKA, I; PAJEVA, I; YANEV, S et al.Xenobiotica (London. Print). 2002, Vol 32, Num 12, pp 1063-1077, issn 0049-8254, 15 p.Article

Human N-demethylation of (S)-mephenytoin by cytochrome P450S 2C9 and 2B6KO, J.-W; DESTA, Z; FLOCKHART, D. A et al.Drug metabolism and disposition. 1998, Vol 26, Num 8, pp 775-778, issn 0090-9556Article

Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitorFAN, Peter W; CHUNGANG GU; MARSH, Sandra A et al.Drug metabolism and disposition. 2003, Vol 31, Num 1, pp 28-36, issn 0090-9556, 9 p.Article

Cytochrome P-450 2B6 is responsible for interindividual variability of Propofol hydroxylation by human liver microsomesCOURT, Michael H; DUAN, Su X; HESSE, Leah M et al.Anesthesiology (Philadelphia). 2001, Vol 94, Num 1, pp 110-119, issn 0003-3022Article

Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapineLEHR, Thorsten; JING YUAN; HALL, David et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 11, pp 721-730, issn 1744-6872, 10 p.Article

Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamideEKHART, Corine; DOODEMAN, Valerie D; RODENHUIS, Sjoerd et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 6, pp 515-523, issn 1744-6872, 9 p.Article

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenzWANG, Jue; SÖNNERBORG, Anders; RANE, Anders et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 3, pp 191-198, issn 1744-6872, 8 p.Article

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadoneKHARASCH, Evan D; HOFFER, Christine; WHITTINGTON, Dale et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 3, pp 250-269, issn 0009-9236, 20 p.Article

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liverLANG, Thomas; KLEIN, Kathrin; FISCHER, Joachim et al.Pharmacogenetics (London). 2001, Vol 11, Num 5, pp 399-415, issn 0960-314XArticle

Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomesHESSE, Leah M; PING HE; KRISHNASWAMY, Soundararajan et al.Pharmacogenetics (London). 2004, Vol 14, Num 4, pp 225-238, issn 0960-314X, 14 p.Article

The macrophage : a novel system to deliver gene therapy to pathological hypoxiaGRIFFITHS, L; BINLEY, K; IQBALL, S et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 3, pp 255-262, issn 0969-7128Article

CYP2B6 mediates the in vitro hydroxylation of bupropion : Potential drug interactions with other antidepressantsHESSE, Leah M; VENKATAKRISHNAN, Karthik; COURT, Michael H et al.Drug metabolism and disposition. 2000, Vol 28, Num 10, pp 1176-1183, issn 0090-9556Article

Roles of CYP2A6 and CYP2b6 in nicotine C-oxidation by human liver microsomesYAMAZAKI, H; INOUE, K; HASHIMOTO, M et al.Archives of toxicology. 1999, Vol 73, Num 2, pp 65-70, issn 0340-5761Article

Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected CambodiansBERTRAND, Julie; CHOU, Monidarin; RICHARDSON, Danielle M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 12, pp 868-876, issn 1744-6872, 9 p.Article

Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activityFAUCETTE, Stephanie R; HAWKE, Roy L; LECLUYSE, Edward L et al.Drug metabolism and disposition. 2000, Vol 28, Num 10, pp 1222-1230, issn 0090-9556Article

Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomesGRANVIL, C. P; MADAN, A; SHARKAWI, M et al.Drug metabolism and disposition. 1999, Vol 27, Num 4, pp 533-541, issn 0090-9556Article

Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoinHEYN, H; WHITE, R. B; STEVENS, J. C et al.Drug metabolism and disposition. 1996, Vol 24, Num 9, pp 948-954, issn 0090-9556Article

Isoflurane-chlorodifluoroethene interaction in human liver microsomes : role of cytochrome P4502B6 in potentiation of haloethene metabolismBAKER, M. T; OLSON, M. J; YING WANG et al.Drug metabolism and disposition. 1995, Vol 23, Num 1, pp 60-64, issn 0090-9556Article

  • Page / 3